IIV

CCRM Fertility Broadens North American Footprint By Adding The Advanced IVF Institute to its Network

Retrieved on: 
Wednesday, August 2, 2023
Advocate Lutheran General Hospital, Medicine, Reproductive medicine, University, Honors colleges and programs, Infertility, Parkland Memorial Hospital, Rosalind Franklin University of Medicine and Science, Research, Gynaecology, IVF, Hospital of the University of Pennsylvania, Fertility, Fertility preservation, MD, Patient, Physician, IIV, Fellow, Education minister, Obstetrics, Hospital, Immunology, AAGL, International Society, Birth control, Science, Northwestern University

CHICAGO, Aug. 2, 2023 /PRNewswire/ -- CCRM Fertility, a global pioneer in fertility treatment, research and science, has added The Advanced IVF Institute, to its rapidly expanding fertility treatment and family-building network. Dr. Charles Miller leads two Chicago-area locations and provides cutting-edge fertility treatments, including in vitro fertilization (IVF), fertility preservation and reproductive surgery.

Key Points: 
  • CHICAGO, Aug. 2, 2023 /PRNewswire/ -- CCRM Fertility , a global pioneer in fertility treatment, research and science, has added The Advanced IVF Institute , to its rapidly expanding fertility treatment and family-building network.
  • Dr. Charles Miller leads two Chicago-area locations and provides cutting-edge fertility treatments, including in vitro fertilization (IVF), fertility preservation and reproductive surgery.
  • For more than 35 years, CCRM Fertility has helped transform lives through exceptional fertility care.
  • As an internationally renowned expert in minimally invasive gynecologic surgery and in the treatment of infertility, Dr. Miller founded The Advanced IVF Institute in 2008.

Influenza Vaccines Global Market Report 2022: Increase in Government Support and Surveillance Regarding Vaccination Against Influenza Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, July 4, 2022
Infectious Diseases, Pharmaceutical, Health, IIV, Baloxavir marboxil, Influenza, Country, Technology, Vaccine, Safety

The "Influenza Vaccines: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Influenza Vaccines: Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • The report explains critical trends in the influenza vaccine industry.
  • It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.
  • This report study includes only human vaccines; animal vaccines have not been considered in this report.

Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by Vaxart

Retrieved on: 
Thursday, November 18, 2021
Shed, Cell Host & Microbe, Coronavirus, Refrigeration, HPV, Safety, Risk, Injury, Biomedical Advanced Research and Development Authority, Compliance, Stanford School, Clinical trial, SEC, CCR9, TLR3, Lancet, Department, Vaccine, BARDA, Vaccination, Immunology, Death, VXA, Microorganism, Stanford University, Research, GLOBE, Phase, Dis, Tablet, Patent, Development, RSV, FDA, Report, Quality control, CDC, Infection, Respiratory syncytial virus, NASDAQ, IIV, Norovirus, Pharmaceutical industry

Results of the Phase II study were the first to show that VXA-A1.1 offered greater protection against viral shedding than the injected IIV.

Key Points: 
  • Results of the Phase II study were the first to show that VXA-A1.1 offered greater protection against viral shedding than the injected IIV.
  • Random forest-based machine learning models were used to define high-dimensional cellular correlates between the immune profiling and viral shedding data.
  • Human influenza virus challenge identifies cellular correlates of protection for oral vaccination.
  • Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study.

Eastern Union Names TJ Liebes to Position of Senior Underwriter

Retrieved on: 
Wednesday, October 13, 2021
Time, Eastern Union Railway, IIV, Fannie Mae, Howell, Fairleigh Dickinson University, TJ, Freddie Mac, Family, Financial services, Real estate

NEW YORK, Oct. 13, 2021 /PRNewswire/ -- Eastern Union , one of the country's largest commercial real estate finance firms, has named TJ Liebes to the position of senior underwriter.

Key Points: 
  • NEW YORK, Oct. 13, 2021 /PRNewswire/ -- Eastern Union , one of the country's largest commercial real estate finance firms, has named TJ Liebes to the position of senior underwriter.
  • Mr. Liebes had previously begun his career at Eastern Union, where he originated new loan opportunities.
  • "TJ has a notable record of accomplishment as a loan underwriter," said Ira Zlotowitz, president and co-founder of Eastern Union.
  • "After initially working with Eastern Union on the brokerage side, TJ Liebes decided to turn his attention to serving an owner," Mr. Zlotowitz said.